The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels

Julie Espallergues (1, 2) , Takayoshi Mamiya , Monique Vallée (3) , Takenao Koseki , Toshitaka Nabeshima , Jamal Temsamani , Claude Laruelle , Tangui Tm Maurice (2)

1 IGF - Institut de Génomique Fonctionnelle
2 MMDN - Mécanismes moléculaires dans les démences neurodégénératives
3 Aquitaine

Domaines: Neurosciences

Julie Espallergues, Takayoshi Mamiya, Monique Vallée, Takenao Koseki, Toshitaka Nabeshima, et al.. The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels. Neuropharmacology, 2012, 62 (1), pp.492-502. ⟨10.1016/j.neuropharm.2011.09.005⟩. ⟨hal-02323757⟩